Advertisement
- Investor's Business Daily
Dow Jones Futures Rise, Carvana Skyrockets; Stock Market Erases Fed Gains
The stock market round-tripped big initial gains as AI plays such as Nvidia retreated. Carvana soared late on earnings.
- Reuters
Moderna quarterly sales beat expectations but plummet from previous year
Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was higher. Sales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ expectations of $97.5 million. The Cambridge, Massachusetts-based drugmaker reaffirmed that it expects to receive approval from regulators for its respiratory syncytial virus (RSV) vaccine in time for it to be included in this fall's U.S. vaccine campaign.
Advertisement
Personalize
Sign in for a personalized experience and quick access to your favorite teams.Sign In
Advertisement
Advertisement